Boston, MA -- (SBWIRE) -- 08/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Hatteras Financial Corp. (NYSE:HTS), TASER International, Inc. (NASDAQ:TASR), Immunomedics, Inc. (NASDAQ:IMMU), Bill Barrett Corporation (NYSE:BBG)
Hatteras Financial Corp. (NYSE:HTS) shares declined 0.11% to $17.85. The company on July 23 announced financial results for the quarter ended June 30, 2013. During the quarter ended June 30, 2013, the Company earned net income available to common shareholders of $65.3 million, or $0.66 per diluted common share, compared to net income of $61.8 million, or $0.62 per diluted common share, during the quarter ended March 31, 2013. Net interest income for the quarter ended June 30, 2013 was $63.4 million, compared to $71.4 million for the quarter ended March 31, 2013 reflecting the decreasing yield on the portfolio.
How Should Investors Trade HTS After The Recent Volatility? Get Free Report Here
TASER International, Inc. (NASDAQ:TASR) shares jumped 1.61% to $11.37. The company on August 14 announced the Surprise Police Department will issue AXON flex™ on-officer cameras and EVIDENCE.com service for all patrol officers following a year-long research and training period. Frazier says department research also discovered that other communities reported declines in police encounter complaints after body cameras were put into use.
How Should Investors Trade TASR After The Recent Volatility? Get Free Report Here
Immunomedics, Inc. (NASDAQ:IMMU) shares dropped 3.23% to $5.40. The company on August 14 announced that the combination of epratuzumab and rituximab, as a front-line therapy of patients with newly diagnosed follicular lymphoma (FL), produced a high complete response rate and prolonged time to disease progression. Final results from the Phase II CALGB 50701 study sponsored by the National Cancer Institute Study Group, Cancer and Leukemia Group B (CALGB), was published online in the journal Cancer.
Is IMMU A Good Buy After The Recent Price Movement? Find Out Here
Bill Barrett Corporation (NYSE:BBG) shares increased 1.84% to $21.03. Canaccord Genuity initiated coverage on shares of Bill Barrett in a research note released on August 19. The firm issued a buy rating and a $28.00 target price on the stock.
Additionally, the company on August 1 reported second quarter 2013 results. Net income in the second quarter of 2013 was $14.3 million, or $0.30 per diluted common share, compared with net income of $3.3 million in the second quarter of 2012. Adjusted net income for the second quarter of 2013 was a loss of $9.1 million, or ($0.19) per diluted common share, compared with a loss of $2.4 million, or ($0.05) per diluted common share, in the second quarter of 2012.
Is BBG A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)